Globus Medical (GMED) said Thursday its board has authorized a share buyback program of up to $500 million.
The timing and number of shares to be repurchased will be determined by the company's management and will depend on factors like market price of the shares, market conditions, and others, Globus said.
The company's shares were rising 3.8% in recent after-hours activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.